Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
Diabetologia ( IF 8.4 ) Pub Date : 2024-11-07 , DOI: 10.1007/s00125-024-06314-1 Aikaterini Eleftheriadou,David Riley,Sizheng S Zhao,Philip Austin,Gema Hernández,Gregory Y H Lip,Timothy L Jackson,John P H Wilding,Uazman Alam
中文翻译：
解决评估 SGLT2 抑制剂和 GLP-1 受体激动剂对糖尿病眼并发症影响的方法学考虑。回复 Tsai Y-H， Hemphill NO， Kurth T.
更新日期：2024-11-07
Diabetologia ( IF 8.4 ) Pub Date : 2024-11-07 , DOI: 10.1007/s00125-024-06314-1 Aikaterini Eleftheriadou,David Riley,Sizheng S Zhao,Philip Austin,Gema Hernández,Gregory Y H Lip,Timothy L Jackson,John P H Wilding,Uazman Alam
中文翻译：
解决评估 SGLT2 抑制剂和 GLP-1 受体激动剂对糖尿病眼并发症影响的方法学考虑。回复 Tsai Y-H， Hemphill NO， Kurth T.
京公网安备 11010802027423号